April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring ... the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and 2 systems ...

Collaboration brings together FreeStyle Libre ® Systems, the world's leading continuous glucose monitoring technology (CGM) 1 with Epic, a healthcare software company, to streamline access to CGM data ...

The latest version of Abbott's FreeStyle Libre continuous glucose ... Libre 2 flash CGM systems remain available to patients and listed on the NHS Drug Tariff. The FreeStyle Libre 3 system ...

April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM ... integrate data from its world-leading 1 Libre CGM systems directly into Epic's ...

Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to vie ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...